Article
Impact of T-cell receptor and B-cell receptor repertoire on the recurrence of early stage lung adenocarcinoma.
Experimental cell research - 15 Sept 2020
Liu Jie, Yang Xiao, Lu Xianfeng, Zhang Liang, Luo Wei, Cheng Yi, Zhang Lei, Yang Yuxin, Dai Nan, Xu Yaping, Guan Yanfang, Xiao Hualiang, Li Mengxia, Wang Dong
Abstract excerpt
Surgical resection is the only curative treatment for patients with early stage non-small cell lung cancer. However, approximately 33% of non-small cell lung cancer patients recur with the stage I disease, which may be attributed to a deficiency in antitumor immunity. In the present study, for early stage lung adenocarcinoma patients with early recurrence and early non-recurrence, we investigated the quantity of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.